David S. Boyer

Retina Vitreous Associates Medical Group

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy”.

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

JAMA Ophthalmology(2021)10.1001/jamaophthalmol.2021.2809

N/A

4.4DataRank · unranked

148 citations

Charles C. Wykoff, David S. Boyer, Jeffrey S. Heier, W. Lloyd Clark, Andrés Emanuelli +10 more

Self-Supervised Learning for Improved Optical Coherence Tomography Detection of Macular Telangiectasia Type 2

JAMA Ophthalmology(2024)10.1001/jamaophthalmol.2023.6454

N/A

0DataRank · unranked

12 citations

Lea Scheppke, Meghana Kshirsagar, Yue Wu, Rahul Dodhia, Roberto Bonelli +57 more

Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial

EClinicalMedicine(2025)10.1016/j.eclinm.2025.103430

N/A

0DataRank · unranked

10 citations

Vitaliy Zak, Víctor H. González, Ninel Z. Gregori, Sai H. Chavala, Subrata Batabyal +17 more